Ultimovacs
Menu Close ✕
  • About
    • About Ultimovacs
    • Team
    • Board of directors
  • Technology
    • Technology overview
    • Immunotherapy
    • Clinical studies
  • Investors
    • Shares
    • Reports and presentations
    • Investor relations contacts
    • Analyst coverage
    • Governance
    • News
  • Contact
Ultimovacs  –  Investors  –  Analyst coverage

Analyst coverage

  • ABG Sundal Collier Viktor Sundberg +46 8 566 286 41 viktor.sundberg@abgsc.se
  • ABG Sundal Collier Øystein Lodgaard +47 22 01 60 26 oystein.lodgaard@abgsc.no
  • DNB Markets Patrik Ling +46 8 473 48 43 patrik.ling@dnb.se
  • DNB Markets Jon Berggren +46 8 473 48 31 jon.berggren@dnb.se
  • Edison Investment Research Dr Jonas Peciulis +44 (0)20 3077 5728 healthcare@edisongroup.com
E-mail: mail@ultimovacs.com
Phone number: +47 413 80 080
Ullernchausséen 64
0379 Oslo
Norway
View in Google Maps

Technology

  • Technology
  • Clinical studies
  • Immunotherapy

Ultimovacs

  • About Ultimovacs
  • Team
  • Board of directors
  • Contact us

Investors

  • Share information
  • Financial reports
  • Investor relations contacts
  • News
Copyright © Ultimovacs ASA 2021